References
- BehçetHÜber rezidivierende aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den GenitalienDermatol Wochenschr19373611521157
- MarshallSEBehçet’s diseaseBest Pract Res Clin Rheumatol200418329131115158742
- CrespoJRibeiroJJesusEMouraAReisCPortoABehçet’s disease: particular features at the central zone of PortugalWechslerBGodeauPBehçet’s DiseaseInternational Congress series 1037AmsterdamExcerpta Medica1993207210
- Al-DalaanAAl BallaaSAl SukatiMMousaMBahabriSBiyariTThe prevalence of Behçet’s disease in Al-Qassim region of Saudi ArabiaHamzaMBehçet’s DiseaseTunisPub Adhoua1997170172
- Assaad-KhalilSHKamelFAIsmailEAStarting a regional registry for patients with Behçet’s disease in North West Nile Delta region in EgyptHamzaMBehçet’s DiseaseTunisPub Adhoua1997173176
- González-GayMAGarcía-PorrúaCBrañasFLópez-LázaroLOlivieriIEpidemiologic and clinical aspects of Behçet’s disease in a defined area of Northwestern Spain, 1988–1997J Rheumatol200027370370710743812
- AzizlerliGKöseAASaricaRPrevalence of Behçet’s disease in Istanbul, TurkeyInt J Dermatol2003421080380614521694
- Al-RawiZSNedaAHPrevalence of Behçet’s disease among IraqisAdv Exp Med Biol2003528374112918657
- KurosawaMInabaYNishibuANationwide epidemiological survey of Behçet’s disease in 2003 in JapaneseClin Exp Rheumatol2004224 Suppl 34S84
- KrauseIYankevichAFraserAPrevalence and clinical aspects of Behçet’s disease in the north of IsraelClin Rheumatol200726455556016897122
- SalvaraniCPipitoneNCatanosoMGEpidemiology and clinical course of Behçet’s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based studyArthritis Rheum200757117117817266063
- DavatchiFJamshidiARBanihashemiATWHO-ILAR COPCORD Study (Stage 1, Urban Study) in IranJ Rheumatol2008357138418464299
- ZhangZHeFShiYBehcet’s disease seen in China: analysis of 334 casesRheumatol Int3201333364564822527133
- YaziciHTüzünYPazarliHInfluence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndromeAnn Rheum Dis19844367837896524980
- KaklamaniVGVaiopoulosGKaklamanisPGBehçet’s diseaseSemin Arthritis Rheum19982741972179514126
- MizukiNInokoHOhnoSPathogenic gene responsible for the predisposition of Behçet’s diseaseInt Rev Immunol199714133489203025
- YaziciHAkokanGYalçinBMüftüoğluAThe high prevalence of HLA-B5 in Behçet’s diseaseClin Exp Immunol1977302259261606446
- De MenthonMLavalleyMPMaldiniCGuillevinLMahrAHLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studiesArthritis Rheum200961101287129619790126
- LehnerTThe role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet’s diseaseInt Rev Immunol199714121329203024
- HamzaouiKAyedKSlimAHamzaMTouraineJNatural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet’s diseaseClin Exp Immunol199079128342154346
- NussenblattRBUveitis in Behçet’s diseaseInt Rev Immunol199714167799203027
- HirohataTKuratsuneMNomuraAJimiSPrevalence of Behçet’s syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and JapanHawaii Med J19753472442461165185
- No authors listedCriteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s DiseaseLancet19903358697107810801970380
- Suzuki KurokawaMSuzukiNBehcet’s diseaseClin Exp Med200441102015598081
- KobayashiTKishimotoMSwearingenCJDifferences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet’s syndrome for patients in the US and Japan: data from a large, three-center cohort studyMod Rheumatol201323354755322752504
- DavatchiFDiagnosis/classification criteria for Behcet’s diseasePatholog Res Int2012201260792121961081
- YurdakulSYaziciHBehçet’s syndromeBest Pract Res Clin Rheumatol200822579380919028364
- IdeguchiHSudaATakenoMUedaAOhnoSIshigatsuboYBehçet disease: evolution of clinical manifestationsMedicine (Baltimore)201190212513221358436
- AlpsoyEZouboulisCCEhrlichGEMucocutaneous lesions of Behcet’s diseaseYonsei Med J200748457358517722228
- SharquieKEAl-ArajiAHatemAOral pathergy test in Behçet’s diseaseBr J Dermatol2002146116816911852922
- Tugal-TutkunIOnalSAltan-YayciogluRHuseyin AltunbasHUrganciogluMUveitis in Behçet disease: an analysis of 880 patientsAm J Ophthalmol2004138337338015364218
- VerityDHWallaceGRVaughanRWStanfordMRBehçet’s disease: from Hippocrates to the third millenniumBr J Ophthalmol20038791175118312928293
- SakaneTTakenoMSuzukiNInabaGBehçet’s diseaseN Engl J Med1999341171284129110528040
- HatemiG1BaharHUysalSThe pustular skin lesions in Behcet’s syndrome are not sterileAnn Rheum Dis200463111450145215479894
- YaziciHTüzünYPazarliHInfluence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndromeAnn Rheum Dis19844367837896524980
- DavatchiFChams-DavatchiCGhodsiZDiagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the timeClin Rheumatol20113091151115521365194
- YaziciHTuzlaciMYurdakulSA controlled survey of sacroiliitis in Behcet’s diseaseAnn Rheum Dis19814065585597332375
- DiriEMatCHamuryudanVYurdakulSHizliNYaziciHPapulopustular skin lesions are seen more frequently in patients with Behçet’s syndrome who have arthritis: a controlled and masked studyAnn Rheum Dis200160111074107611602484
- KaracaMHatemiGSutNYaziciHThe papulopustular lesion/arthritis cluster of Behçet’s syndrome also clusters in familiesRheumatology (Oxford)20125161053106022286924
- HatemiGFreskoITascilarKYaziciHIncreased enthesopathy among Behçet’s syndrome patients with acne and arthritis: an ultrasonography studyArthritis Rheum20085851539154518438817
- CheonJHÇelikAFKimWHBehçet’s disease: gastrointestinal involvementYaziciYYaziciHBehçet’s syndromeNew YorkSpringer2010165188
- ShimizuTEhrlichGEInabaGHayashiKBehçet disease (Behçet syndrome)Semin Arthritis Rheum197984223260382361
- LakhanpalSTaniKLieJTKatohKIshigatsuboYOhokuboTPathologic features of Behçet’s syndrome: a review of Japanese autopsy registry dataHum Pathol19851687907954018777
- GürlerABoyvatATürsenUClinical manifestations of Behçet’s disease: an analysis of 2147 patientsYonsei Med J19973864234279509912
- EbertECGastrointestinal manifestations of Behçet’s diseaseDig Dis Sci200954220120718594975
- TursenUGurlerABoyvatAEvaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s diseaseInt J Dermatol200342534635112755969
- IdeguchiHSudaATakenoMNeurological manifestations of Behçet’s disease in Japan: a study of 54 patientsJ Neurol201025761012102020127350
- KalraSSilmanAAkman-DemirGDiagnosis and management of Neuro-Behçet’s disease: international consensus recommendationsJ Neurol201426191662167624366648
- YaziciHBehçet’s syndrome: where do we stand?Am J Med20021121757611812412
- TohméA1AounNEl-RassiBGhayadEVascular manifestations of Behçet’s disease. Eighteen cases among 140 patientsJoint Bone Spine200370538438914563470
- MaderRZivMAdawiMMaderRLaviIThrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet’s diseaseJ Rheumatol199926112404240810555901
- LeibaMSeligsohnUSidiYThrombophilic factors are not the leading cause of thrombosis in Behçet’s diseaseAnn Rheum Dis200463111445144915479893
- EspinosaGFontJTàssiesDVascular involvement in Behçet’s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulinAm J Med20021121374311812405
- LakhanpalSTaniKLieJTKatohKIshigatsuboYOhokuboTPathologic features of Behcet’s syndrome: a review of Japanese autopsy registry dataHum Pathol19851687907954018777
- SaadounDAsliBWechslerBLong-term outcome of arterial lesions in Behcet disease: a series of 101 patientsMedicine (Baltimore)2012911182422198498
- SeyahiEMelikogluMAkmanCPulmonary artery involvement and associated lung disease in Behcet disease; a series of 47 patientsMedicine (Baltimore)2012911354822210555
- HatemiGSilmanABangDEULAR Expert CommitteeEULAR recommendations for the management of Behçet diseaseAnn Rheum Dis200867121656166218245110
- MatCYurdakulSUysalSA double-blind trial of depot corticosteroids in Behçet’s syndromeRheumatology (Oxford)200645334835216263779
- OkadaAADrug therapy in Behçet’s diseaseOcul Immunol Inflamm200082859110980680
- TuncerSYilmazSUrganciogluMTugal-TutkunIResults of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet diseaseJ Ocul Pharmacol Ther200723439540117803439
- YurdakulSMatCTüzünYA double-blind trial of colchicine in Behçet’s syndromeArthritis Rheum20014411268611710724
- DavatchiFSadeghi AbdollahiBTehrani BanihashemiAColchicine versus placebo in Behçet’s disease; randomized, double-blind, controlled crossover trialMod Rheumatol200919554254919597921
- YaziciHPazarliHBarnesCGA controlled trial of azathioprine in Behçet’s syndromeN Engl J Med199032252812852404204
- HamuryudanVOzyazganYHizliNAzathioprine in Behcet’s syndrome: effects on long-term prognosisArthritis Rheum19974047697749125262
- SaadounDWechslerBTerradaCAzathioprine in severe uveitis of Behçet’s diseaseArthritis Care Res (Hoboken)201062121733173820665749
- HoSClipstoneNTimmermannLThe mechanism of action of cyclosporin A and FK506Clin Immunol Immunopathol1996803 Pt 2S40S458811062
- OzyazganYYurdakulSYaziciHLow dose cyclosporin A versus pulsed cyclophosphamide in Behçet’s syndrome: a single masked trialBr J Ophthalmol19927642412431390495
- MasudaKNakajimaAUrayamaANakaeKKogureMInabaGDouble-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s diseaseLancet198918647109310962566048
- KotakeSHigashiKYoshikawaKSasamotoYOkamotoTMatsudaHCentral nervous system symptoms in patients with Behçet disease receiving cyclosporine therapyOphthalmology1999106358658910080218
- HatemiGYaziciYYaziciHBehçet’s syndromeRheum Dis Clin North Am201339224526123597962
- Akman-DemirGAyranciOKurtuncuMVanliENMutluMTugal-TutkunICyclosporine for Behçet’s uveitis: is it associated with an increased risk of neurological involvement?Clin Exp Rheumatol2008264 Suppl 50S84S9019026121
- YasuiKKobayashiNYamazakiTAgematsuKThalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammationCurr Pharm Des200511339540115723633
- HamuryudanVMatCSaipSThalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebocontrolled trialAnn Intern Med199812864434509499327
- HelloMBarbarotSBastuji-GarinSRevuzJChosidowOUse of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysisMedicine (Baltimore)201089317618220453604
- SaenzAAusejoMSheaBWellsGWelchVTugwellPPharmacotherapy for Behcet’s syndromeCochrane Database Syst Rev20002CD00108410796413
- TsambaosDEichelbergDGoosMBehçet’s syndrome: treatment with recombinant leukocyte alpha-interferonArch Dermatol Res198627843353363740944
- KötterIGünaydinIZierhutMStübigerNThe use of interferon alpha in Behçet disease: review of the literatureSemin Arthritis Rheum200433532033515079763
- Tugal-TutkunIMudunAUrganciogluMEfficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trialArthritis Rheum20055282478248416052571
- SfikakisPPBehçet’s disease: a new target for anti-tumour necrosis factor treatmentAnn Rheum Dis200261Suppl 2ii51ii5312379622
- TrioloGVadalàMAccardo-PalumboAAnti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet’s diseaseAnn Rheum Dis200261656056112006336
- NiccoliLNanniniCBenucciMLong-term efficacy of infliximab in refractory posterior uveitis of Behcet’s disease: a 24-month follow-up studyRheumatology20074671161116417478466
- SfikakisPPTheodossiadisPGKatsiariCGKaklamanisPMarkomichelakisNNEffect of infliximab on sight-threatening panuveitis in Behçet’s diseaseLancet2001358927829529611498218
- SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseAnn Intern Med2004140540440614996689
- IwataSSaitoKYamaokaKEfficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s diseaseMod Rheumatol201121218419121052764
- AdlerSBaumgartnerIVilligerPMBehçet’s disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysisArthritis Care Res (Hoboken)201264460761122162223
- GiardinaA1FerranteACicciaFVadalàMGiardinaETrioloGOne year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugsRheumatol Int2011311333719859715
- FasanoAD’AgostinoMCaldarolaGFelicianiCDe SimoneCInfliximab monotherapy in neuro-Behçet’s disease: four year follow-up in a long-standing case resistant to conventional therapiesJ Neuroimmunol20112391–210510721911262
- MelikogluMFreskoIMatCShort-term trial of etanercept in Behçet’s disease: a double blind, placebo controlled studyJ Rheumatol20053219810515630733
- KumpLIMoellerKLReedGFKurupSKNussenblattRBLevy-ClarkeGABehçet’s disease: comparing 3 decades of treatment response at the National Eye InstituteCan J Ophthalmol200843446847218711463
- AndoKFujinoYHijikataKIzawaYMasudaKEpidemiological features and visual prognosis of Behçet’s diseaseJpn J Ophthalmol199943431231710482479
- YoshidaAKawashimaHMotoyamaYComparison of patients with Behçet’s disease in the 1980s and 1990sOphthalmology2004111481081515051217